Immatics (IMTX) EBIT Margin (2019 - 2025)

Immatics (IMTX) reported EBIT Margin of 181.09% for Q4 2025, down 26076.0% on a YoY basis from N/an in Q4 2024, and up 81.57% sequentially from 982.48% in Q3 2025.

Immatics (IMTX) EBIT Margin (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of EBIT Margin data on file, last reported at 181.09% in Q4 2025.

  • For the quarter ending Q4 2025, EBIT Margin fell 26076.0% year-over-year to 181.09%; the trailing twelve-month figure through Dec 2025 stood at 490.55% (down 49607.0% YoY), and the FY2025 full-year result was 377.11%, down 35233.0% from the prior year.
  • EBIT Margin advanced to 181.09% in Q4 2025, from 982.48% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 82.16% in Q1 2022 to a low of 1987.02% in Q2 2025.
  • A 5-year average of 302.18% and a median of 159.61% in 2025 frame the typical range for EBIT Margin.
  • Across the five-year window, EBIT Margin surged 174351 bps in 2021 and slumped 189021 bps in 2025, its largest moves.
  • Tracing IMTX's EBIT Margin over 5 years: stood at 108.81% in 2021, then surged by 78 bps to 23.52% in 2022, then plunged by 676 bps to 182.41% in 2023, then soared by 144 bps to 79.66% in 2024, then slumped by 327 bps to 181.09% in 2025.
  • Business Quant data shows IMTX's EBIT Margin at 181.09% in Q4 2025, 982.48% in Q3 2025, and 1987.02% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Immatics 1.14 Bn 1.14 Bn - -181.09%

Historic Data

Download Data
DateValue
Dec 31, 2025 -181.09%
Sep 30, 2025 -982.48%
Jun 30, 2025 -1,987.02%
Mar 31, 2025 -291.60%
Dec 31, 2024 79.66%
Sep 30, 2024 -29.55%
Jun 30, 2024 -96.81%
Mar 31, 2024 -7.93%
Dec 31, 2023 -182.41%
Sep 30, 2023 -473.57%
Jun 30, 2023 -115.21%
Mar 31, 2023 -237.40%
Dec 31, 2022 -23.52%
Sep 30, 2022 -138.13%
Jun 30, 2022 -76.92%
Mar 31, 2022 82.16%
Dec 31, 2021 -108.81%
Sep 30, 2021 -424.86%
Jun 30, 2021 -523.47%
Mar 31, 2021 -324.69%